心血管植入型电子装置患者行磁共振检查的研究进展

doi:10.3969/j.issn.1004-583X.2025.12.012

摘要/Abstract

摘要：

由于心血管植入型电子装置（cardiovascular implantable electronic device，CIED）行磁共振成像（magnetic resonance imaging，MRI）检查存在一定的安全隐患，过去一直被视为绝对禁忌证，并且金属材料带来伪影问题给临床诊断带来难题。近些年随着CIED的创新和MRI技术的优化，已有大量研究证实了其在MRI检查中的安全性，并且图像伪影问题也得到显著改善。本文就CIED患者行MRI检查的安全性和减少金属伪影干扰的最新研究进展做一综述。

关键词: 心律失常, 心性, 心血管植入型电子装置, 磁共振, 安全性, 伪影

中图分类号:

R541.7

周琪, 张云龙, 徐泽升. 心血管植入型电子装置患者行磁共振检查的研究进展[J]. 临床荟萃, 2025, 40(12): 1119-1123.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://www.lchc.cn/CN/10.3969/j.issn.1004-583X.2025.12.012

https://www.lchc.cn/CN/Y2025/V40/I12/1119

参考文献 30

[1]	Meier C, Bietenbeck M, Theofanidou M, et al. First-pass perfusion imaging using cardiovascular magnetic resonance in patients with various cardiac implantable electronic devices[J]. Clin Res Cardiol, 2025,14. doi:10.1007/s00392-025-02636-1.
[2]	Ruiz Mateas F, Pérez MA, García López F, et al. Magnetic resonance imaging in patients with cardiac implantable electronic devices: The RESONANCE Spanish registry[J]. Europace, 2024, 26(11):euae277. doi:10.1093/europace/euae277.
[3]	Russo RJ, Gakenheimer-Smith L, Birgersdotter-Green UM, et al. HRS call-to-action: Improved MRI access for patients with cardiovascular implantable electronic devices[J]. Heart Rhythm, 2025, 22(9):e821-e836. doi:10.1016/j.hrthm.2025.04.028.
[4]	Barison A, Baritussio A, Cipriani A, et al. Cardiovascular magnetic resonance: What clinicians should know about safety and contraindications[J]. Int J Cardiol, 2021, 331:322-328. doi:10.1016/j.ijcard.2021.02.003.
[5]	Fogante M, Volpato G, Esposto Pirani P, et al. Cardiac magnetic resonance and cardiac implantable electronic devices: Are they truly still “Enemies”[J]. Medicina (Kaunas), 2024, 60(4):522. doi:10.3390/medicina60040522.
[6]	Ainslie M, Miller C, Brown B, et al. Cardiac MRI of patients with implanted electrical cardiac devices[J]. Heart, 2014, 100(5):363-369. doi:10.1136/heartJNL-2013-304324. pmid: 23872585
[7]	Yang E, Suzuki M, Nazarian S, et al. Magnetic resonance imaging safety in patients with cardiac implantable electronic devices[J]. Trends Cardiovasc Med, 2022, 32(7):440-447. doi:10.1016/j.tcm.2021.08.001.
[8]	De Leon-Benedetti LS, Ramirez-Suarez KI, Otero HJ, et al. How we do it: Cardiac implantable devices are not a contraindication to MRI: Time for a paradigm shift[J]. Pediatr Radiol, 2024, 54(6):863-875. doi:10.1007/s00247-024-05902-y. pmid: 38488925
[9]	Indik JH, Gimbel JR, Abe H, et al. 2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices[J]. Heart Rhythm, 2017, 14(7):e97-e153. doi:10.1016/j.hrthm.2017.04.025.
[10]	Poh PG, Liew C, Yeo C, et al. Cardiovascular implantable electronic devices: A review of the dangers and difficulties in MR scanning and attempts to improve safety[J]. Insights Imaging, 2017, 8(4):405-418. doi:10.1007/s13244-017-0556-3.
[11]	Miller JD, Nazarian S, Halperin HR. Implantable electronic cardiac devices and compatibility with magnetic resonance imaging[J]. J Am Coll Cardiol, 2016, 68(14):1590-1598. doi:10.1016/j.jacc.2016.06.068. pmid: 27687201
[12]	Rowe MK, Shanahan L. Cardiac implantable electronic devices: An update[J]. Aust J Gen Pract, 2024, 53(7):430-435. doi:10.31128/AJGP-05-23-6847. pmid: 38957055
[13]	Martin ET, Coman JA, Shellock FG, et al. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla[J]. J Am Coll Cardiol, 2004, 43(7):1315-1324. doi:10.1016/j.jacc.2003.12.016. pmid: 15063447
[14]	Nazarian S, Hansford R, Roguin A, et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices[J]. Ann Intern Med, 2011, 155(7):415-424. doi:10.7326/0003-4819-155-7-201110040-00004. pmid: 21969340
[15]	Nazarian S, Hansford R, Rahsepar AA, et al. Safety of magnetic resonance imaging in patients with cardiac devices[J]. N Engl J Med, 2017, 377(26):2555-2564. doi:10.1056/NEJMoa1604267.
[16]	Ma YD, Watson RE Jr, Olson NE, et al. Safety of magnetic resonance imaging in patients with surgically implanted permanent epicardial leads[J]. Heart Rhythm, 2023, 20(8):1111-1118. doi:10.1016/j.hrthm.2023.04.003.
[17]	Vuorinen AM, Paakkanen R, Karvonen J, et al. Magnetic resonance imaging safety in patients with abandoned or functioning epicardial pacing leads[J]. Eur Radiol, 2022, 32(6):3830-3838. doi:10.1007/s00330-021-08469-6.
[18]	Fluschnik N, Tahir E, Erley J, et al. 3 Tesla magnetic resonance imaging in patients with cardiac implantable electronic devices: A single centre experience[J]. Europace, 2023, 25(2):571-577. doi:10.1093/europace/euac213.
[19]	Barison A, Ricci F, Pavon AG, et al. Cardiovascular magnetic resonance in patients with cardiac electronic devices: Evidence from a multicenter study[J]. J Clin Med, 2023, 12(20):6673. doi:10.3390/jcm12206673.
[20]	Bhuva AN, Moralee R, Brunker T, et al. Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices[J]. Eur Heart J, 2022, 43(26):2469-2478. doi:10.1093/eurheartj/ehab350.
[21]	Lanz H, Strauβ K, Höpler J, et al. Safety of magnetic resonance imaging in patients with cardiac implantable electronic devices[J]. J Cardiovasc Dev Dis, 2024, 11(10):313. doi:10.3390/jcdd11100313.
[22]	Lee EM, Ibrahim EH, Dudek N, et al. Improving MR image quality in patients with metallic implants[J]. Radiographics, 2021, 41(4):E126-E137. doi:10.1148/rg.2021200092.
[23]	Sasaki T, Hansford R, Zviman MM, et al. Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators[J]. Circ Cardiovasc Imaging, 2011, 4(6):662-670. doi:10.1161/CIRCIMAGING.111.965764. pmid: 21946701
[24]	Vuorinen AM, Lehmonen L, Karvonen J, et al. Reducing cardiac implantable electronic device-induced artefacts in cardiac magnetic resonance imaging[J]. Eur Radiol, 2023, 33(2):1229-1242. doi:10.1007/s00330-022-09059-w.
[25]	Buˇci'c D, Hrabak-Paar M. Multimodality imaging in patients with implantable loop recorders: Tips and tricks[J]. Hellenic J Cardiol, 2024, 77:93-105. doi:10.1016/j.hjc.2023.12.001.
[26]	Bhuva AN, Kellman P, Graham A, et al. Clinical impact of cardiovascular magnetic resonance with optimized myocardial scar detection in patients with cardiac implantable devices[J]. Int J Cardiol, 2019, 279:72-78. doi:10.1016/j.ijcard.2019.01.005. pmid: 30642645
[27]	Löbe S, Paetsch I, Hilbert S, et al. Evaluation of the right heart using cardiovascular magnetic resonance imaging in patients with cardiac devices[J]. Int J Cardiol, 2020, 316:266-271. doi:10.1016/j.ijcard.2020.05.002. pmid: 32389768
[28]	Almeida AG, António N, Saraiva C, et al. Consensus document on magnetic resonance imaging in patients with cardiac implanted electronic devices. Documento de consenso sobre a realização de ressonância magnética em doentes com dispositivos cardíacos electrónicos implantados[J]. Rev Port Cardiol (Engl Ed), 2021, 40(1):41-52. doi:10.1016/j.repc.2020.05.009.
[29]	Bishara D, Hong K, Davó-Jiménez M, et al. Highly accelerated real-time cine MRI pulse sequence for cardiac implantable electronic devices and arrhythmias[J]. Radiol Cardiothorac Imaging, 2025, 7(6):e240554. doi:10.1148/ryct.240554.
[30]	Soni A, Srinivasa V, TB, Janorkar P, et al. Superior metal artifact reduction with MAVRIC-SL versus STIR in lumbar spine instrumentation: A retrospective analysis of 84 patients[J]. Global Spine J, 2025, 12. doi:10.1177/21925682251397909.

心血管植入型电子装置患者行磁共振检查的研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 30

相关文章 15

编辑推荐

Metrics

本文评价

[1]	刘佳, 杨丰宇, 郭梦雅, 吴卓威, 张瀚文, 王译萱, 陈春红, 张芳. 低剂量利伐沙班用于肾功能不全的高龄心房颤动患者的安全性和有效性[J]. 临床荟萃, 2025, 40(6): 509-512.
[2]	唐旭, 左庄, 杨凯, 张志源, 王淇, 董信春, 苟云久. 抗血管生成药物联合化疗对恶性胸膜间皮瘤的疗效和安全性:更新的系统评价与meta分析[J]. 临床荟萃, 2025, 40(4): 304-312.
[3]	黄兴舟, 郑卫华, 张树桐, 陈燕浩. 载药微球与常规支气管动脉化疗栓塞术治疗晚期非小细胞肺癌的临床疗效及安全性对比[J]. 临床荟萃, 2025, 40(3): 243-250.
[4]	季万里, 马周, 石郁喜, 孙为生. 青年脊髓硬脊膜动静脉瘘1例并文献复习[J]. 临床荟萃, 2025, 40(3): 262-265.
[5]	张迎秋, 张津, 葛世豪, 陈俊敏. 成人DWI脑皮质“花边征”1例并文献复习[J]. 临床荟萃, 2024, 39(9): 821-824.
[6]	散丹, 甄瑾. 脊髓硬脊膜动静脉瘘1例并文献复习[J]. 临床荟萃, 2024, 39(9): 825-827.
[7]	岳江红, 王恒, 蔡钢, 张选明, 彭曦. 索格列净治疗2型糖尿病疗效和安全性的meta分析[J]. 临床荟萃, 2024, 39(7): 581-592.
[8]	刘秀颖, 崔凯歌, 刘丽莹, 吴艳凯, 于佳琪, 杨冀萍. 基于静息态功能磁共振成像探讨卒中后疲劳的中枢机制[J]. 临床荟萃, 2024, 39(5): 401-407.
[9]	刘峻宇, 张天财, 张柏娥, 李宜洲, 李亚飞, 刘红斌, 段丽萍, 张全英, 王怡君, 孟繁华, 孙敏. 阿司匹林肠溶片在健康成年受试者中的生物等效性[J]. 临床荟萃, 2024, 39(5): 433-439.
[10]	杨铭益, 潘迎紫, 陈勇. 影像学评估脊柱关节炎的研究进展[J]. 临床荟萃, 2024, 39(4): 376-379.
[11]	覃巧玲, 莫让辉, 陈新怡. HIV和HCV共感染患者基于含依非韦伦方案抗HIV下直接抗HCV治疗的疗效和安全性[J]. 临床荟萃, 2024, 39(10): 921-924.
[12]	李亚, 杜涛明, 邱世香, 陈超, 钟立明. 伴有抑郁症状肝癌患者脑功能连接研究[J]. 临床荟萃, 2023, 38(6): 532-536.
[13]	尚蒙, 王礼琳. 沙库巴曲/缬沙坦对慢性心力衰竭患者心律失常影响的研究进展[J]. 临床荟萃, 2023, 38(5): 459-464.
[14]	陈珺. 钠-葡萄糖转运蛋白2抑制剂在2型糖尿病患者中用药安全性的研究进展[J]. 临床荟萃, 2023, 38(11): 1042-1047.
[15]	钟叶, 徐俊, 刘陈平, 武刚. 3.0T磁共振双参数成像及多参数成像对前列腺良恶性肿瘤诊断价值的比较[J]. 临床荟萃, 2022, 37(8): 723-727.